ARCHIVES

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

NCI: The Times Have Been “Confusing,” Acting NCI Director Niederhuber Admits in Memo.

June 9, 2006

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion

November 4, 1994

NCI To Evaluate Chernobyl Effects On Soviet Health

November 23, 1990

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990